“…The utility of prostate specific antigen (PSA) has been well documented in the diagnosis [ 1,2,3], staging [3,4], and management [4,5] of patients with prostatic adenocarcinoma. PSA is a serine protease, elaborated by the prostatic ductal epithelium, is detectable in the serum of males (and females in low levels), and it was first isolated from seminal plasma [6,7]. Although it is elevated in patients with prostatic adenocarcinoma, a number of nonmalignant conditions of the prostate may cause elevations in PSA, specifically benign prostatic hyperplasia (BPH), prostatic massage, surgical prostatic manipulation, and prostatitis [3, 6,8].…”